Soothing Scents Blog

Oregon Health and Science University conducted a limited size clinical trial of QueaseEASE® testing efficacy and satisfaction. Findings showed 85% of users had total relief of nausea and were satisfied with QueaseEASE® AUTHOR(S): Jennifer Francis, RN, Lynn Truscott, RN DATE: April 2017 READ THE FULL STUDY BELOW: INTRODUCTION CHH Short Stay recognized that PONV was a challenge with day stay patients.

A study conducted at Stephens Memorial Hospital showed that 90% of patients using QueaseEASE® experienced some relief from their nausea,  with 50% experiencing complete relief. AUTHOR(S): Ambulatory Surgery Center Postoperative RNs DATE: January 2014 READ THE FULL STUDY BELOW: DEMOGRAPHICS Product used on 20 patients (2 male, 18 female) Mean age = 41.2 years RESULTS 50% – Total Relief from

A Queens Medical Center trial found a 15-minute decrease in PACU stay when nauseated patients used QueaseEASE®, as well as a 37% decrease in Phenergan use and more than a 50% decrease of Kytril administration.  In addition, 82% of patients felt that QueaseEASE® helped relieve their nausea. AUTHOR(S): Wendy Hunter, RN, Queen’s Medical Center DATE: July 2012 READ THE FULL STUDY

Clinical trials by Bon Secour St. Francis Health System concluded that 70% of patients reported nausea relief after using QueaseEASE®, both in PACU and post-discharge. In addition, 97% were satisfied with their treatment for nausea. AUTHOR: Sandy Rotsted BSN, RN DATE: March 2013 READ THE FULL STUDY BELOW: RESULTS 61 – Total QueaseEASE® Used. 10 – Not used according to